BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26700070)

  • 1. Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.
    Medici V; McClave SA; Miller KR
    Curr Gastroenterol Rep; 2016 Jan; 18(1):2. PubMed ID: 26700070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Obesity.
    Kumar RB; Aronne LJ
    Endocrinol Metab Clin North Am; 2020 Jun; 49(2):265-273. PubMed ID: 32418589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced metabolic syndrome.
    Wofford MR; King DS; Harrell TK
    J Clin Hypertens (Greenwich); 2006 Feb; 8(2):114-9. PubMed ID: 16470080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current views on the metabolic syndrome and the effects of antipsychotic drugs].
    Fodor M
    Psychiatr Hung; 2011; 26(3):196-200. PubMed ID: 21799222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain associated with use of psychotropic medications.
    Sachs GS; Guille C
    J Clin Psychiatry; 1999; 60 Suppl 21():16-9. PubMed ID: 10548137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update.
    Verhaegen AA; Van Gaal LF
    Curr Obes Rep; 2021 Mar; 10(1):1-13. PubMed ID: 33400222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription medications: a modifiable contributor to obesity.
    Cheskin LJ; Bartlett SJ; Zayas R; Twilley CH; Allison DB; Contoreggi C
    South Med J; 1999 Sep; 92(9):898-904. PubMed ID: 10498166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric medication induced obesity: an aetiologic review.
    Virk S; Schwartz TL; Jindal S; Nihalani N; Jones N
    Obes Rev; 2004 Aug; 5(3):167-70. PubMed ID: 15245385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medications associated with weight gain.
    Malone M
    Ann Pharmacother; 2005 Dec; 39(12):2046-55. PubMed ID: 16278256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hyperphagia: what can we learn from psychiatric medications?
    Jensen GL
    JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
    Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
    Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
    Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes medications and body weight.
    Mitri J; Hamdy O
    Expert Opin Drug Saf; 2009 Sep; 8(5):573-84. PubMed ID: 19538102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.